AI Article Synopsis

  • - The review focuses on the current evidence surrounding balloon sinuplasty for treating pediatric chronic rhinosinusitis (CRS), which is ten years after the initial clinical consensus statement that deemed the treatment as lacking sufficient evidence.
  • - Recent findings show that balloon sinuplasty is not cost-effective compared to procedures like adenoidectomy and endoscopic sinus surgery, although it offers benefits like shorter surgery times and less tissue damage.
  • - The conclusion suggests that pediatric otolaryngologists should prioritize adenoidectomy and consider endoscopic sinus surgery, as balloon sinuplasty's effectiveness remains unproven, highlighting the need for further research.

Article Abstract

Purpose Of Review: This year marks 10 years from the publication of the clinical consensus statement on pediatric chronic rhinosinusitis (CRS). Balloon sinuplasty did not meet criteria for consensus at that time because there was insufficient evidence on its efficacy and safety. The purpose of this review is to summarize the current evidence on balloon sinuplasty treatment for pediatric CRS.

Recent Findings: Balloon sinuplasty is not a cost-effective measure compared to adenoidectomy and endoscopic sinus surgery (ESS). In the pediatric population, benefits include short operative time, reduced tissue manipulation, and potential for decreased antibiotic courses. Alternatively, balloon dilation has increased equipment costs and there is a lack of robust prospective data that fully elucidates balloon sinuplasty's role in the management of pediatric CRS.

Summary: Pediatric otolaryngologists should continue to perform first-line adenoidectomy and consider ESS based on imaging and other validated clinical scoring systems. Balloon sinuplasty has not yet been proven as an effective treatment for pediatric CRS and further large-scale investigations are required to overcome its lack of cost-effectiveness.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOO.0000000000001016DOI Listing

Publication Analysis

Top Keywords

balloon sinuplasty
20
treatment pediatric
12
sinuplasty treatment
8
pediatric chronic
8
chronic rhinosinusitis
8
purpose review
8
pediatric
7
balloon
6
sinuplasty
5
evaluation balloon
4

Similar Publications

Short- and long-term costs of sinus balloon sinuplasty and middle meatal antrostomy.

Eur Arch Otorhinolaryngol

December 2024

Department of Otorhinolaryngology, Head and Neck Surgery, Tampere University Hospital, PO Box 272, FI-33101, Tampere, Finland.

Purpose: To evaluate and compare hospital related costs, postoperative costs, and the long-term costs of maxillary balloon sinuplasty (BSP) and middle meatal antrostomy (MMA) in patients with chronic rhinosinusitis.

Methods: Data were collected from patient registers on 88 patients treated with BSP and 240 patients treated with MMA between 2011 and 2017. Information was also gathered on the related costs of surgery, material, postoperative ward care, and any extra patient visits that took place within one year following the operation.

View Article and Find Full Text PDF
Article Synopsis
  • - The review focuses on the current evidence surrounding balloon sinuplasty for treating pediatric chronic rhinosinusitis (CRS), which is ten years after the initial clinical consensus statement that deemed the treatment as lacking sufficient evidence.
  • - Recent findings show that balloon sinuplasty is not cost-effective compared to procedures like adenoidectomy and endoscopic sinus surgery, although it offers benefits like shorter surgery times and less tissue damage.
  • - The conclusion suggests that pediatric otolaryngologists should prioritize adenoidectomy and consider endoscopic sinus surgery, as balloon sinuplasty's effectiveness remains unproven, highlighting the need for further research.
View Article and Find Full Text PDF

Objective: Current research compared traditional FESS, balloon sinuplasty, and powered instruments for CRS efficiency.

Methods: A prospective comparison analysis of 150 CRS patients who received FESS. The surgical method divided the patients into three groups: Group A (conventional FESS, = 50), Group B (balloon sinuplasty, = 50), and Group C (powered instrumentation, = 50).

View Article and Find Full Text PDF

Introduction: Balloon sinuplasty (BSP) is a common treatment modality used in the management of chronic rhinosinusitis (CRS). Although it has gained popularity, minimal self-reported data on its utilization and complications have been reported. The goal of this study was to describe current practices and complications experienced during frontal sinus BSP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!